Patients are being harmed because FDA doesn't commit sufficient resources to enforce federal requirements for hospitals and manufacturers to report adverse outcomes caused by medical devices, according to Larry Pilot, one of the original authors of FDA's 510(k) device clearance process.
![Conversation with The Cancer Letter](https://cdn.cancerletter.com/media/2020/11/18170519/qa-300x300.jpg)
![Conversation with The Cancer Letter](https://cdn.cancerletter.com/media/2020/11/18170519/qa-300x300.jpg)